Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Asset Utilization Ratio: 2016-2025

Historic Asset Utilization Ratio for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to 0.22.

  • Editas Medicine's Asset Utilization Ratio rose 29.75% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year increase of 29.75%. This contributed to the annual value of 0.08 for FY2024, which is 50.14% down from last year.
  • Per Editas Medicine's latest filing, its Asset Utilization Ratio stood at 0.22 for Q3 2025, which was up 37.13% from 0.16 recorded in Q2 2025.
  • Over the past 5 years, Editas Medicine's Asset Utilization Ratio peaked at 0.22 during Q3 2025, and registered a low of 0.03 during Q3 2021.
  • Over the past 3 years, Editas Medicine's median Asset Utilization Ratio value was 0.15 (recorded in 2024), while the average stood at 0.13.
  • As far as peak fluctuations go, Editas Medicine's Asset Utilization Ratio crashed by 77.26% in 2021, and later skyrocketed by 323.12% in 2024.
  • Over the past 5 years, Editas Medicine's Asset Utilization Ratio (Quarterly) stood at 0.04 in 2021, then grew by 2.94% to 0.04 in 2022, then skyrocketed by 312.75% to 0.16 in 2023, then crashed by 37.95% to 0.10 in 2024, then rose by 29.75% to 0.22 in 2025.
  • Its Asset Utilization Ratio was 0.22 in Q3 2025, compared to 0.16 in Q2 2025 and 0.12 in Q1 2025.